EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia‐Related Synaptic and Cognitive Impairments
Advanced Science · 2024
DOI: 10.1002/advs.202406979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Cuiping Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Basic Medicine, Key Laboratory of Education Ministry/Hubei Province of China for Neurological Disorders, Ton…. Hauptthemen laut MEDLINE: Schizophrenia, Cognitive Dysfunction, Rats, Sprague-Dawley, Erythropoietin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Innovation Team, Department of Science and Technology of Hubei Province.
Abstract (Originalsprache)
Schizophrenia (SZ) is a chronic and severe mental illness associated with psychiatric symptoms, cognitive deficits, and social dysfunction. Current clinical interventions only limit relief of psychiatric symptoms and have minimal impact on cognitive impairments. Erythropoietin (EPO), known for its role in neurogenesis and synaptic plasticity, is significantly low in SZ patients. However, the role of EPO deficiency in SZ‐associated cognitive deficits remains unclear. In this study, we used the MK801‐induced SZ rat model to show that EPO levels were significantly decreased, correlating with cognitive impairments. EPO supplementation mitigated apoptosis, synaptic damage, and cognitive impairments caused by MK801. RNA‐sequencing and Western blot analysis revealed increased expression of growth arrest and DNA damage 45b (GADD45b) in MK801‐treated rats, reversed by EPO supplementation. Moreover, overexpression of GADD45b exacerbated neuronal loss and cognitive impairments in male Sprague‐Dawley rats, while downregulation of GADD45b rescued these SZ‐related pathologies. Notably, the benefits of EPO supplementation on SZ pathology were blocked by GADD45b overexpression. Inhibition of p38 MAPK, a GADD45b target, reduced MK801‐induced apoptosis and synaptic damage. These findings uncover a novel etiopathogenic mechanism of SZ‐related cognitive impairments, driven by EPO deficiency and the activation of the GADD45b/p38 MAPK axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, School of Basic Medicine, Key Laboratory of Education Ministry/Hubei Province of China for Neurological Disorders, Tongji Medical College, Huazhong University of Science and Technology, Wu…
- Department of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
- Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan, 430030, China.
- Hubei Key Laboratory of Cognitive and Affective Disorders, Institute of Biomedical Sciences, School of Medicine, Jianghan University, China.
- Co-innovation Center of Neuroregeneration, Nantong University, Nantong, 226001, China.
- Shenzhen Huazhong University of Science and Technology Research Institute, Shenzhen, 518000, China.
ORCID-Profile: Xiaochuan Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Innovation Team
- Department of Science and Technology of Hubei Province
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Guo, C., Li, W., Liu, Y., Tao, X., Mahaman, Y. A. R., Wang, J., Liu, R., Li, S., & Wang, X. (2024). EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia‐Related Synaptic and Cognitive Impairments. Advanced Science. https://doi.org/10.1002/advs.202406979
Vancouver
Guo C, Li W, Liu Y, Tao X, Mahaman YAR, Wang J, et al. EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia‐Related Synaptic and Cognitive Impairments. Advanced Science. 2024. doi:10.1002/advs.202406979
BibTeX
@article{Guo2024,
author = {Guo, Cuiping and Li, Wensheng and Liu, Yi and Tao, Xiaoqing and Mahaman, Yacoubou Abdoul Razak and Wang, Jianzhi and Liu, Rong and Li, Shusheng and Wang, Xiaochuan},
title = {EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia‐Related Synaptic and Cognitive Impairments},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202406979}
}
EUVIMED